ArticleBriefings in bioinformatics2026
DeepPANB: integrating protein language model with PaiNN equivariant graph neural networks for prediction of protein-nucleic acid binding sites.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Protein-nucleic acid interactions are fundamental to various biological processes, and accurately identifying nucleic acid binding sites on proteins is essential for understanding gene regulation mechanisms and advancing drug design. Here, we present DeepPANB, an effective deep learning model for the issue. DeepPANB is built upon the Polarizable Atom Interaction Neural Network (PaiNN) architecture, an E(3)-equivariant graph neural network, which explicitly couples scalar and vector channels through lightweight message passing, thereby enabling effective modeling of the direction- and distance-dependent residue interactions. DeepPANB integrates multiple feature types including sequence embeddings from the Ankh pretrained model, residue-nucleotide pairwise propensity extracted by us from the large-scale datasets, as well as residue intrinsic disorder, physicochemical properties, and structural descriptors. To our best knowledge, PaiNN and Ankh are first introduced here for protein-nucleic acid binding site prediction. On the protein-DNA test set, DeepPANB achieves state-of-the-art performance, outperforming the existing methods. On protein-RNA test set, DeepPANB, fine-tuned with the feature types unchanged, shows competitive performance. Overall, DeepPANB demonstrates robust and generalizable performance, providing an effective tool for protein-nucleic acid binding site prediction. Freely available at https://github.com/ChunhuaLab/DeepPANB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.